A Study of Home Administration of Pemetrexed as Maintenance Treatment for Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC)

NCT01473563 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Nonsquamous Non-Small Cell Neoplasm of Lung
Non-Small Cell Lung Cancer Metastatic
Non-Small Cell Lung Cancer Stage IIIB

Interventions

DRUG: Pemetrexed

Sponsor

Eli Lilly and Company